Socio-economic effects and cost saving potential of remote patient monitoring (SAVE-HM trial)

International Journal of Cardiology

Volumn 169, Issue 6, 2013, Pages 402-407

  Perl, S ^a   Stiegler, P ^a   Rotman, B ^a   Prenner, G ^a   Lercher, P ^a   Anelli Monti, M ^a   Sereinigg, M ^a   Riegelnik, V ^a   Kvas, E ^b   Kos, C ^a   Heinzel, F R ^a   Tscheliessnigg, K H ^a   Pieske, B ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Hermessoft Biostatistics and Data Management   (Austria)

Author keywords

ICD; Pacemaker; Remote monitoring; SAVE

Indexed keywords

AGED; ARTICLE; AUSTRIA; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST CONTROL; DEVICE SAFETY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; IMPLANTED HEART PACEMAKER; LEAD DEFECT; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; OUTPATIENT CARE; PATIENT MONITORING; PRIMARY PREVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; REMOTE SENSING; SOCIOECONOMICS; SUDDEN CARDIAC DEATH; TREATMENT INDICATION;

AGED; AGED, 80 AND OVER; COST SAVINGS; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PACEMAKER, ARTIFICIAL; SOCIOECONOMIC FACTORS; TELEMEDICINE;

EID: 84888001201     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.019     Document Type: Article

References (53)

1. R.T. Stevenson, D. Lugg, R. Gray, D. Hollis, M. Stoner, and J.L. Williams Pacemaker implantation in the extreme elderly J Interv Card Electrophysiol 33 2012 51 58
2. S. Brullmann, W. Dichtl, and U. Paoli Comparison of benefit and mortality of implantable cardioverter-defibrillator therapy in patients aged >/= 75 years versus those < 75 years Am J Cardiol 109 2012 712 717
3. B.P. Betensky, C.M. Tschabrunn, and E.S. Zado Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators Heart Rhythm 9 2012 884 891
4. Z. Koyak, J.R. de Groot, and I.C. Van Gelder Implantable cardioverter defibrillator therapy in adults with congenital heart disease: who is at risk of shocks? Circ Arrhythm Electrophysiol 5 2012 101 110
5. Y. Wakabayashi, K. Yamazaki, and Y. Narumi Implantable cardioverter defibrillator for progressive hypertrophic cardiomyopathy in a patient with LEOPARD syndrome and a novel PTPN11 mutation Gln510His Am J Med Genet A 155A 2011 2529 2533
6. A. Merante, P. Gareri, and E. Bonacci Brugada syndrome (BS) and syncope: a complex therapeutic issue Arch Gerontol Geriatr 55 3 2011 706 708
7. M. Saeed, M. Razavi, C.G. Neason, and S. Petrutiu Rationale and design for programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock (PROVIDE) study Europace 13 2011 1648 1652
8. D. Wilson, B. Shi, S. Harding, N. Lever, and P. Larsen Implantable cardioverter defibrillators (ICDs): a long-term view Intern Med J 42 5 2011 554 561
9. F. Osman, S. Krishnamoorthy, A. Nadir, P. Mullin, A. Morley-Davies, and J. Creamer Safety and cost-effectiveness of same day permanent pacemaker implantation Am J Cardiol 106 2010 383 385
10. C.C. de Cock, J. Elders, and N.M. van Hemel Remote monitoring and follow-up of cardiovascular implantable electronic devices in the Netherlands: an expert consensus report of the Netherlands Society of Cardiology Neth Heart J 20 2012 53 65
11. A.F. Folino, R. Breda, P. Calzavara, F. Migliore, S. Iliceto, and G. Buja In-home controls of pacemakers in debilitated elderly patients Geriatr Gerontol Int 12 2012 30 35
12. C.H. Li, Y.J. Lin, and J.L. Huang Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy J Cardiovasc Electrophysiol 23 2012 750 756
13. A. Alcaraz, J. Gonzalez-Zuelgaray, and F. Augustovski Cost effectiveness of implantable cardioverter-defibrillators for patients who are at risk for sudden death in Argentina Value Health 14 2011 S33 S38
14. H. Franqui-Rivera, and J.C. Sotomonte Implantable cardioverter- defibrillators for primary prevention of sudden cardiac death in patients with left ventricular systolic dysfunction: 14 years after MADIT P R Health Sci J 30 2011 78 83
15. F. Leyva, I. Fernandez Lozano, and J. Morgan Cardioverter-defibrillators: a cost or an investment? Europace 13 Suppl. 2 2011 ii25 ii31
16. A. Kadish, and J. Goldberger Selecting patients for ICD implantation: are clinicians choosing appropriately? JAMA 305 2011 91 92
17. B.A. Moorman Service models for remote healthcare monitoring systems Biomed Instrum Technol 2010 64 68 [Suppl. Home Healthcare]
18. P. Mabo, F. Victor, and P. Bazin A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial) Eur Heart J 33 2011 1105 1111
19. O. Bikou, M. Licka, S. Kathoefer, H.A. Katus, and A. Bauer Cost savings and safety of ICD remote control by telephone: a prospective, observational study J Telemed Telecare 16 2010 403 408
20. F. Halimi, and F. Cantu Remote monitoring for active cardiovascular implantable electronic devices: a European survey Europace 12 2010 1778 1780
21. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary Heart Rhythm 5 2008 934 955
22. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities Heart Rhythm 5 2008 e1 e62
23. A.E. Epstein Benefits of the implantable cardioverter-defibrillator J Am Coll Cardiol 52 2008 1122 1127
24. M. Marzegalli, M. Lunati, and M. Landolina Remote monitoring of CRT-ICD: the multicenter Italian CareLink evaluation - ease of use, acceptance, and organizational implications Pacing Clin Electrophysiol 31 2008 1259 1264
25. V. Barbaro, P. Bartolini, and R. Bernarducci A portable unit for remote monitoring of pacemaker patients J Telemed Telecare 3 1997 96 102
26. S. Spencker, N. Coban, L. Koch, A. Schirdewan, and D. Muller Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure Europace 11 2009 483 488
27. A.F. Folino, F. Chiusso, and G. Zanotto Management of alert messages in the remote monitoring of implantable cardioverter defibrillators and pacemakers: an Italian single-region study Europace 13 2011 1281 1291
28. C. Perings, W.R. Bauer, and H.J. Bondke Remote monitoring of implantable-cardioverter defibrillators: results from the Reliability of IEGM Online Interpretation (RIONI) study Europace 13 2011 221 229
29. S.M. Al-Khatib, J.P. Piccini, D. Knight, M. Stewart, N. Clapp-Channing, and G.D. Sanders Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial J Cardiovasc Electrophysiol 21 2010 545 550
30. C. Tompkins, and C.A. Henrikson Optimal strategies for the management of antiplatelet and anticoagulation medications prior to cardiac device implantation Cardiol J 18 2011 103 109
31. M. Metais, A. Hebrard, and A. Duparc Cardiac implantable devices: surveillance of surgical site infections and assessment of professional practices Arch Cardiovasc Dis 104 2011 325 331
32. B.D. Powell, Y.M. Cha, and S.J. Asirvatham Implantable cardioverter defibrillator electrogram adjudication for device registries: methodology and observations from ALTITUDE Pacing Clin Electrophysiol 34 2011 1003 1012
33. G. Marinskis, and L. van Erven Deactivation of implanted cardioverter-defibrillators at the end of life: results of the EHRA survey Europace 12 2010 1176 1177
34. A. Przybylski, J. Zakrzewska-Koperska, and A. Maciag Technical and practical aspects of remote monitoring of implantable cardioverter-defibrillator patients in Poland - preliminary results Kardiol Pol 67 2009 505 511
35. D.A. Theuns, M. Rivero-Ayerza, P. Knops, J.C. Res, and L. Jordaens Analysis of 57,148 transmissions by remote monitoring of implantable cardioverter defibrillators Pacing Clin Electrophysiol 32 Suppl. 1 2009 S63 S65
36. D.G. Jones, D.H. Mortsell, and D. Rajaruthnam Permanent pacemaker implantation early and late after heart transplantation: clinical indication, risk factors and prognostic implications J Heart Lung Transplant 30 2011 1257 1265
37. J.J. Goldberger, N.P. Johnson, and C. Gidea Significance of asymptomatic bradycardia for subsequent pacemaker implantation and mortality in patients > 60 years of age Am J Cardiol 108 2011 857 861
38. A. Daoulah, A.A. Alsheikh-Ali, and A.H. Ocheltree Outcome after implantable cardioverter-defibrillator in patients with Brugada syndrome: the Gulf Brugada syndrome registry J Electrocardiol 45 2011 327 332
39. C. Hadid, J. Almendral, and M. Ortiz Incidence, determinants, and prognostic implications of true pleomorphism of ventricular tachycardia in patients with implantable cardioverter-defribillators: a substudy of the DATAS trial Circ Arrhythm Electrophysiol 4 2011 33 42
40. R.F. Pedretti, A. Curnis, and R. Massa Proportion of patients needing an implantable cardioverter defibrillator on the basis of current guidelines: impact on healthcare resources in Italy and the USA. Data from the ALPHA study registry Europace 12 2010 1105 1111
41. B.J. Wong, M.A. Cifaldi, S. Roy, D.C. Skonieczny, and S. Stavrakas Analysis of drug and administrative costs allowed by U.S. private and public third-party payers for 3 intravenous biologic agents for rheumatoid arthritis J Manag Care Pharm 17 2011 313 320
42. G. Boriani, H. Burri, and L.G. Mantovani Device therapy and hospital reimbursement practices across European countries: a heterogeneous scenario Europace 13 Suppl. 2 2011 ii59 ii65
43. J.G. Cleland, A.P. Coletta, N. Freemantle, D. Ahmed, P. Rubis, and A.L. Clark Clinical trials update from the American Heart Association meeting 2009: HEAAL, FAIR-HF, J-CHF, HeartMate II, PACE and a meta-analysis of dose-ranging studies of beta-blockers in heart failure Eur J Heart Fail 12 2010 197 201
44. N. Varma, J. Michalski, A.E. Epstein, and R. Schweikert Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial Circ Arrhythm Electrophysiol 3 2010 428 436
45. N. Varma Rationale and design of a prospective study of the efficacy of a remote monitoring system used in implantable cardioverter defibrillator follow-up: the Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) study Am Heart J 154 2007 1029 1034
46. G.H. Crossley, A. Boyle, H. Vitense, Y. Chang, and R.H. Mead The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts J Am Coll Cardiol 57 2011 1181 1189
47. J.G. Cleland, A.P. Coletta, L. Buga, D. Ahmed, and A.L. Clark Clinical trials update from the American College of Cardiology meeting 2010: DOSE, ASPIRE, CONNECT, STICH, STOP-AF, CABANA, RACE II, EVEREST II, ACCORD, and NAVIGATOR Eur J Heart Fail 12 2010 623 629
48. Ch. Elsner, and G. Hindricks Nutzen der Telemedizin im Bereich der Kardiologie: Evaluation ökonomischer Effekte im Rahmen der REFORM-Studie Telemedizinführer Deutschland 67 2009
49. L. Guedon-Moreau, P. Chevalier, and C. Marquie Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory Eur Heart J 31 2010 2246 2252
50. L. Guédon-Moreau, D. Lacroix, and N. Sadoul A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial Eur Heart J 34 8 2013 605 614
51. D. Wetzel, and D. von Mallek Information on the policies of the Medical Devices Safety Act Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 52 2009 577 578
52. R.P. Ricci, L. Morichelli, and L. Quarta Long-term patient acceptance of and satisfaction with implanted device remote monitoring Europace 12 2010 674 679
53. F. Halimi, J. Clementy, P. Attuel, X. Dessenne, and W. Amara Optimized post-operative surveillance of permanent pacemakers by home monitoring: the OEDIPE trial Europace 10 2008 1392 1399